tradingkey.logo
tradingkey.logo
Search

Intuitive Surgical Inc

ISRG
Add to Watchlist
450.060USD
-3.430-0.76%
Close 05/08, 16:00ETQuotes delayed by 15 min
159.50BMarket Cap
53.81P/E TTM

Intuitive Surgical Inc

450.060
-3.430-0.76%
View Detailed Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-0.76%

5 Days

-1.69%

1 Month

-2.64%

6 Months

-19.63%

Year to Date

-20.53%

1 Year

-16.37%

Key Insights

Intuitive Surgical Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 46 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 581.15.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Intuitive Surgical Inc's Score

Industry at a Glance

Industry Ranking
46 / 206
Overall Ranking
131 / 4494
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

49°C

Very Low
Very High
Positive

Intuitive Surgical Inc Highlights

StrengthsRisks
Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 41.28% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 10.06B.
Undervalued
The company’s latest PE is 53.81, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 316.45M shares, decreasing 0.47% quarter-over-quarter.
Held by Brandes Investmen
Star Investor Brandes Investmen holds 523.00 shares of this stock.

Analyst Rating

Based on 35 analysts
Buy
Current Rating
581.152
Target Price
+28.47%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Intuitive Surgical Inc Info

Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
Ticker SymbolISRG
CompanyIntuitive Surgical Inc
CEORosa (David J)
Websitehttps://www.intuitive.com/en-us/about-us/company
KeyAI